Une étude exploratoire visant à explorer la sécurité, l'acceptabilité et le schéma de saignement vaginal de trois systèmes intra-utérins médicamenteux libérant étonogestrel (Étude P06060)

Résumé succinct

This is a phase 2, randomized, active-controlled, parallel-group, multicenter, single-blind trial of three different doses of etonogestrel releasing medicated intrauterine systems (ENG-MIUS) in healthy parous women in need for contraception. The primary trial objective is to explore safety and acceptability of three doses of an ENG-releasing medicated intrauterine system (ENG-MIUS) as compared to Multiload-cu 375®.